No matches

35 search results for: diagnosis

Pulmonology

GOLD Diagnosis and Assessment of COPD

4 min

expert video

This short video presentation outlines the diagnosis and assessment of COPD according to the GOLD report, focusing on clinical features and assessment goals.

Heterogeneity and Unpredictability: Challenges With the <b>Diagnosis</b> and Evaluation of CSU

Dermatology

Heterogeneity and Unpredictability: Challenges With the Diagnosis and Evaluation of CSU

10 min

expert video

In this video from EADV 2025, Dr. Netchiporouk discusses the clinical features, diagnosis, and burden of CSU

Dermatology

Prurigo Nodularis: The Patient Journey

5 min

interactivity

An interactive tool highlighting the disease burden, impact and management of prurigo nodularis throughout the patient journey before diagnosis, during diagnosis and during treatment.

FeNO Is a Noninvasive Biomarker That Can Support <b>Diagnosis</b> and Management for Asthma Patients

Pulmonology

FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients

3 min

Infographic

Learn how FeNO, a noninvasive biomarker for type 2 inflammation, can be used to optimize care for asthma patients.

Diagnosing CSU: Hives, Angioedema, and Differential <b>Diagnosis</b>

Dermatology

Diagnosing CSU: Hives, Angioedema, and Differential Diagnosis

2 min

expert video

Dr. Elena Netchiporouk illustrates key considerations for diagnosing CSU at EADV 2025.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: Saudi ArabiaChange country/region